Beth A. Soffer

687 total citations
9 papers, 514 citations indexed

About

Beth A. Soffer is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Nephrology. According to data from OpenAlex, Beth A. Soffer has authored 9 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Nephrology. Recurrent topics in Beth A. Soffer's work include Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (4 papers) and Renal function and acid-base balance (2 papers). Beth A. Soffer is often cited by papers focused on Blood Pressure and Hypertension Studies (7 papers), Hormonal Regulation and Hypertension (4 papers) and Renal function and acid-base balance (2 papers). Beth A. Soffer collaborates with scholars based in United States and Chile. Beth A. Soffer's co-authors include Charles S. Sweet, Allan I. Goldberg, J. Howard Pratt, Jackson T. Wright, Brian L. Wiens, Shahnaz Shahinfar, Thomas G. Wells, Wayne Shaw, Zhongxin Zhang and F. Cano and has published in prestigious journals such as Hypertension, American Journal of Hypertension and Clinical Therapeutics.

In The Last Decade

Beth A. Soffer

9 papers receiving 488 citations

Peers

Countries citing papers authored by Beth A. Soffer

Since Specialization

Citations

This map shows the geographic impact of Beth A. Soffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth A. Soffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth A. Soffer more than expected).

Fields of papers citing papers by Beth A. Soffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth A. Soffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth A. Soffer. The network helps show where Beth A. Soffer may publish in the future.

Co-authorship network of co-authors of Beth A. Soffer

This figure shows the co-authorship network connecting the top 25 collaborators of Beth A. Soffer. A scholar is included among the top collaborators of Beth A. Soffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth A. Soffer. Beth A. Soffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Gastrointestinal side effects of etoricoxib in patients with osteoarthritis: results of the Etoricoxib versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) trial. 2007 ·PubMed ·Herbert S. B. Baraf, (unknown), Maria Greenwald, Jan Brzezicki, Katherine O’Brien, Beth A. Soffer, Adam B. Polis, Steven Bird, Amarjot Kaur, Sean Curtis, (unknown)	67
2	A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension 2006 ·Clinical Therapeutics ·Gilbert W. Gleim, Joseph Rubino, Hongyan Zhang, Shahnaz Shahinfar, Beth A. Soffer, Paulette A. Lyle, Thomas Littlejohn, Peter U. Feig	12
3	A double-blind, dose-response study of losartan in hypertensive children 2005 ·American Journal of Hypertension ·S. Shahinfar, F. Cano, Beth A. Soffer, Tanveer Ahmed, (unknown), Z ZHANG, (unknown), Karl Miller, Bruno Vogt, J Blumer	72
4	A double-blind, placebo-controlled, dose–response study of the effectiveness and safety of lisinopril for children with hypertension 2003 ·American Journal of Hypertension ·Beth A. Soffer	99
5	A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with Hypertension 2002 ·The Journal of Clinical Pharmacology ·Thomas G. Wells, (unknown), Beth A. Soffer, Wayne Shaw, Zhongxin Zhang, (unknown), Shahnaz Shahinfar, (unknown)	103
6	Effects of the angiotensin II receptor antagonist, losartan, in children age 6-16 years with hypertension 2002 ·American Journal of Hypertension ·Beth A. Soffer	1
7	Effects of the ACE inhibitor, enalapril, in children age 6–16 years with hypertension 2000 ·American Journal of Hypertension ·Beth A. Soffer	9
8	Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors 1998 ·Clinical Therapeutics ·Robert Zorba Paster, Duane Snavely, (unknown), (unknown), Allan I. Goldberg, Beth A. Soffer, Charles S. Sweet	28
9	Effects of Losartan on a Background of Hydrochlorothiazide in Patients With Hypertension 1995 ·Hypertension ·Beth A. Soffer, Jackson T. Wright, J. Howard Pratt, Brian L. Wiens, Allan I. Goldberg, Charles S. Sweet	123

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact